Estévez-Loureiro Rodrigo, Tavares Da Silva Marta, Baz-Alonso José Antonio, Caneiro-Queija Berenice, Barreiro-Pérez Manuel, Calvo-Iglesias Francisco, González-Ferreiro Rocio, Puga Luis, Piñón Miguel, Íñiguez-Romo Andrés
Cardiovascular Research Group, Department of Cardiology, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IIS Galicia Sur), Servizo Galego de Saude, University of Vigo, Vigo, Spain.
Department of Cardiovascular Surgery, University Hospital Alvaro Cunqueiro, Vigo, Spain.
Front Cardiovasc Med. 2022 Sep 23;9:987122. doi: 10.3389/fcvm.2022.987122. eCollection 2022.
Acute mitral regurgitation (MR) may develop in the setting of an acute myocardial infarction (AMI) because of papillary muscle dysfunction or rupture. Severe acute MR in this scenario is a life-threatening complication associated with hemodynamic instability and pulmonary edema, and has been linked to a worse prognosis even after reperfusion. Patients treated solely with medical therapy have the highest mortality rates. Surgery has been the only treatment strategy until recently, but the results of the technique are hindered by high rates of morbidity and mortality. Therefore, the development of less invasive interventions for correcting MR would be ideal. We aimed to review the current role of transcatheter interventions in this clinical setting.
急性二尖瓣反流(MR)可能在急性心肌梗死(AMI)的情况下因乳头肌功能障碍或破裂而发生。在这种情况下,严重的急性MR是一种危及生命的并发症,与血流动力学不稳定和肺水肿相关,即使在再灌注后也与较差的预后有关。仅接受药物治疗的患者死亡率最高。直到最近,手术一直是唯一的治疗策略,但该技术的结果受到高发病率和死亡率的阻碍。因此,开发侵入性较小的纠正MR的干预措施将是理想的。我们旨在综述经导管干预在这种临床情况下的当前作用。